Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Sanofi submits candidate diabetes drug lixisenatide for FDA OK
The FDA received Sanofi's application for lixisenatide, or Lyxumia in Europe, to treat diabetes. The drug's European launch is scheduled for this quarter.
Or we can send an email on your behalf